|
Silverberg DS, Wexler D, Blum M, et Al.
The Use of Subcutaneous Erythropoietin
and Intravenous Iron for the Treatment
of the Anemia of Severe, Resistant
Congestive Heart Failure Improves
Cardiac and Renal Function and Functional
Cardiac Class, and Markedly Reduces Hospitalizations
(J Am Coll Cardiol 2000;35:1737– 44) 2000
|
|
Silverberg DS, Wexler D, Sheps D, et Al.
The Effect of Correction of Mild Anemia
in Severe, Resistant Congestive Heart Failure
Using Subcutaneous Erythropoietin and
Intravenous Iron: A Randomized Controlled Study
(J Am Coll Cardiol 2001;37:1775– 80) 2001
|
|
Kalra PR, Collier T, Cowie MR, et Al.
Haemoglobin concentration and prognosis in new cases of heart failure
(THE LANCET • Vol 362 • July 19, 2003) 2003
|
|
Silverberg DS, Wexler D, Blum M, et Al.
The cardio-renal anaemia syndrome: does it exist?
(Nephrol Dial Transplant (2003) 18 [Suppl 8*: viii7-viii12) 2003
|
|
O’Meara E, Clayton T, McEntegart MB, et Al.
Clinical Correlates and Consequences of Anemia in a Broad Spectrum of
Patients With Heart Failure: Results of the Candesartan in Heart Failure:
Assessment of Reduction in Mortality and Morbidity (CHARM) Program
(Circulation. 2006;113: 986-994.) 2006
|
|
Go AS, Yang J, Ackerson LM, et Al.
Hemoglobin Level, Chronic Kidney Disease, and the Risks of
Death and Hospitalization in Adults With Chronic Heart Failure
The Anemia in Chronic Heart Failure: Outcomes and Resource Utilization
(ANCHOR) Study
(Circulation. 2006;113:2713-2723.) 2006
|
|
Bolger AP, Bartlett FR, et Al.
Intravenous Iron Alone for the Treatment
of Anemia in Patients With Chronic Heart Failure
(J Am Coll Cardiol 2006-1225) 2006
|
|
Nanas JN, Matsouka C, Karageorgopoulos D, et Al.
Etiology of Anemia in
Patients With Advanced Heart Failure
(J Am Coll Cardiol 2006-2485) 2006
|
|
Dec GW
Anemia in Heart Failure
Time to Rethink Its
Etiology and Treatment?
(J Am Coll Cardiol 2006 2490) 2006
|
|
Beck-Da-Silva L, Rohde LE, Pereira-Barreto AC, et Al.
Rationale and Design of the IRON-HF Study:
A Randomized Trial to Assess the Effects
of Iron Supplementation in Heart Failure
Patients With Anemia
(J Cardiac Fail 2007;13:14e17) 2007
|
|
Toblli et al.
Intravenous Iron Reduces NT-Pro-Brain
Natriuretic Peptide in Anemic Patients With
Chronic Heart Failure and Renal Insufficiency
(JACC Vol. 50, No. 17) 2007 |
|
Christian Mueller, MD, FESC
B-Type Natriuretic Peptides
and the General Practitioner
(JACC Vol. 50, No. 17) 2007 |
|
Gary S. Francis, MD, FACC, Anne Kanderian, MD
Anemia and Heart Failure
A New Pathway?
(JACC Vol. 50, No. 17) 2007 |
|
| |
|
|
|
Izuel-Rami M, Cuenca J, Garcia JA, et Al.
Efectividad de distintas pautas de tratamiento de la anemia perioperatoria en pacientes ancianos con fractura de cadera
(M. Izuel-Rami et al . Farm Hasp 2005 : 29 :250-257) 2005 |
|
Bisbe E, Rodriguez C, Ruiz A, et Al.
Uso preoperatorio de hierro endovenoso . Una nueva terapeutica
en medicina transfusional
(Rev . Esp . Anestesiol . Reanim. 2005 ; 52 : 536-540) 2005
|
|
Piagnerelli M, Rapotec A, Cotton F, et Al.
Iron Administration in the Critically Ill
(Semin Hematol 43(suppl 6):S23-S27 © 2006) 2006
|
|
García-Erce J, Cuenca J, Muñoz M
Role of Intravenous Iron in Elective and Non-elective Orthopedic Surgery
(Semin Hematol 43(suppl 6):S32-S35 © 2006) 2006
|
|
Muñoz M, Campos A, García-Erce J
Intravenous Iron in Colorectal Cancer Surgery
(Semin Hematol 43(suppl 6):S36-S38 © 2006) 2006
|
|
Muñoz M, Leal-Noval R, García-Erce J
Intravenous Iron in Cardiac Surgery
(Semin Hematol 43(suppl 6):S39-S42 © 2006) 2006
|
|
Muñoz M, Naveira E, Seara J, et Al.
Role of parenteral iron in transfusion requirements after total hip replacement. A pilot study
(Blackwell Publishing Ltd, Transfusion Medicine, 16, 137–142) 2006
|
|
| |
|
|
|
Riaño J, Sánchez L
Manejo de la anemia ferropénica en ginecología y obstetricia con hierro parenteral
(Rev del AWGLA Vol. 1 - No. 2 págs 9-14) 2005
|
|
Canaval H
Abordaje de la anemia ferropénica en la práctica ginecobstétrica
(Rev del AWGLA Vol. 1 - No. 1 págs 18-23) 2005
|
|
Ortiz R
Estudio controlado, aleatorizado, para comparar la efectividad y los efectos colaterales de dos diferentes preparaciones endovenosas de hierro sacarato en pacientes con anemia por deficiencia de hierro
(Rev del AWGLA Vol. 3 - No. 1 págs 50-64) 2007
|
|
Baker W
Iron Deficiency in Pregnancy, Obstetrics, and Gynecology
(HEMATOLOGIC PROBLEMS IN OBSTETRICS, PREGNANCY, AND GYNECOLOGY VOLUME 14 • NUMBER 5 . OCTOBER 2000) 2000
|
|
Perewusnyk G, Huch R, Breymann C
Parenteral iron therapy in obstetrics: 8 years experience with iron–sucrose complex
(British Journal of Nutrition (2002), 88, 3–10) 2002
|
|
Kepczyk T, Cremins J, Long B et Al.
A Prospective, Multidisciplinary Evaluation of Premenopausal Women With Iron-Deficiency Anemia
(Am J Gastroenterol 1999;94:109-115. © 1999 by Am. Coll. of Gastroenterology) 1999
|
|
Rock W, Meeks R
Managing Anemia and Blood Loss in Elective Gynecologic Surgery Patients
(J Reprod Med 2001;46:507-514) 2001)
|
|
Larso B, Bremme K, Clyne N, et Al.
Preoperative treatment of anemic women with epoetin beta
(Acta Obstec Gynecol Scand 2001; 80: 559-562) 2001
|
|
Bhandal N, Russell R
Intravenous versus oral iron therapy for postpartum anaemia
(RCOG 2006 BJOG An International Journal of Obstetrics and Gynaecology 2006; 1248-1252) 2006
|
|
Singh K, Fong Y, Kuperan P
A comparison between intravenous iron polymaltose complex (Ferrum Hausmann) and oral ferrous fumarate in the treatment of iron deficiency in anaemia in pregnancy
(Eu J Haematol 1998; 60: 119-124)) 1998
|
|
Cavill I, Breymann C, Gay C
Iron supplementation in pregnancy and the postpartum
2005
|
|
Rouse D, MacPherson C, Landon M, et Al.
Blood Transfusion and Cesarean Delivery
(Obstet Gynecol 2006-891; 891-897) 2006
|
|
Gredilla E, Gimeno M, Canser E, et Al.
Tratamiento de la anemia en el postparto y en el postoperatorio inmediato de cirugía ginecológica, con hierro intravenoso
(Rev. Esp. Anestesiol. Reanim. 2006; 53: 208-213) 2006
|
|
Breymann C
The Use of Iron Sucrose Complex for Anemia in Pregnancy and the Postpartum Period
(Semin Hematol 43(suppl 6):S28-S31) 2006
|
|
| |
|
|
|
Penninx B, Guralnik J, Onder G, et Al.
Anemia and Decline in Physical Performance among Older Persons
(Am J Med . 2003;115 :104-I10) 2003
|
|
Yee J, Besarab A
Iron Sucrose: The Oldest Iron Therapy Becomes New
(Am J Kidney Dis 40 :1111-1121) 2002
|
|
Abello V, Solano M, Ramírez C, et Al.
Hierro sacarato endovenoso para el tratamiento de la anemia ferropenica en adultos intolerantes al hierro oral
(Acts Med Colomb 2004 ; 29 : 322-327) 2004
|
|
Penninx B, Pluijm S, Lips P, et Al.
Late-Life Anemia Is Associated with Increased Risk of Recurrent Falls
(J Am Geriatr Soc 53:2106–2111, 2005.) 2005
|
|
Gheorghita E, Vulcan G, Mocanu C. et Al.
Venofer - alternativa terapeutica eficienta si sigura a transfuziei de sange in anemia feripriva moderata si severa
(Doc Haematologica Vol. XVI Nr, 1-2 Anul 2006; 28-28) 2006
|
|
James M, Chen Ch, Goddard W, et A.
Risk factors for gastrointestinal malignancy in patients with iron-deficiency anaemia
(Eu J of Gastroenterology & Hepatology 2005, Vol 17 No 11; 1197-1203) 2005
|
|
Auerbach M, Ballard H, Trout J, et Al.
Intravenous Iron Optimizes the Response to Recombinant Human Erythropoietin in Cancer Patients With Chemotherapy-Related Anemia: A Multicenter, Open-Label, Randomized Trial
(J Clin Oncol 22:1301-1307) 2004
|
|
David H
The Rol of Intravenous Iron in Cancer-Related Anemia
(Oncology Vol. 20 No. 8 Sup; 21-24) 2006
|
|
Delfini R, Buzian S, Gomes T, et Al.
O uso intravenoso de sacarato de Hidróxido de Ferro III en pacientes com Anemia Ferropriva
(Rev Assoc Med Bras 2005; 51(6): 323-8) 2005
|
|
Beris P, Maniatis A
Role of Intravenous Iron Therapy in Anemia Management: State of the Art
(Semin Hematol ;s1-s2) 2006
|
|
Heinz L
Iron Metabolism and Iron Supplementation in Anemia of Cancer
(Semin Hematol 43(suppl 6):S13-S17) 2006
|
|
| |
|
|
|
Wagner P
Anemia de la Enfermedad Renal Crónica (ERC)
(Revista del AWGLA, jun 2003; 10-19) 2006
|
|
Abensur H, Gomes M, Bregman R, et Al.
Rol de la deficiencia de Hierro en la Anemia de la Enfermedad Renal Crónica
(Revista del AWG, Vol1 N1;14-23) 2005
|
|
Fishbane S, Fre G, Maesaka J
Reduction in Recombinant Human Erythropoietin Doses by the Use of Chronic Intravenous Iron Supplementation
(American Journal of Kidney Diseases, Vol 26, No 1 (July), 1995 : pp 41-46) 1995
|
|
Pos J, Wilkes B, Michelis M
Iron deficiency in patients with chronic kidney disease: potential role for intravenous iron therapy independent of erythropoietin
(International Urology and Nephrology (2006) 38:719–723) 2006
|
|
Macdougall I, Schaefer R, Silverberg D, et Al.
Educational Statement on the Iron Management of Anemia
(ITO) 2004
|
|
Macdougall I, Khasabov N, Lameire N, et Al.
Anemia Management in CKD (predyalisis)Patients
(ITO) 2005
|
|
Blaustein D, Schwenk M, Chattopadhayay J, et Al.
Recent experience with high-dose intravenous Iron administration
(Kidney Int 2006-s26) 2006
|
|
Phrommintikul A, Haas S, Elsik M, et Al.
Mortality and target haemoglobin concentrations in anaemic patients with chronic kidney disease treated with erythropoietin: a meta-analysis
(Lancet 2007; 369: 381–88) 2007
|
|
Drüeke T, Locatelli F, Clyne N, et Al.
Normalization of Hemoglobin Level in Patients with Chronic Kidney Disease and Anemia
(N Engl J Med 2006;355:2071-84.) 2006
|
|
Macdougall I
Experience With Intravenous Iron in Nephrology
(Semin Hematol 43(suppl 6):S9-S12) 2006 |
|
| |
|
|
|
Madero D
Eficacia y seguridad del complejo de HIDRÓXIDO DE HIERRO FÉRRICO (III) y Polimaltoa (IPC) vs el Hierro aminoquelado en el manejo de la anemia ferropénica en niños
(Revista del AWGLA, enero 2007; 28-39) 2007
|
|
Núñez O, Del Águila C
Estudio controlado de dos compuestos de POLIMALTOSADO FÉRRICO en el tratamiento de Anemia ferropénica en noños de 6 meses a 2 años
(Revista del AWGLA, Vol.1 Nº2; 31-38) 2005
|
|
Del Águila C, Núñez O
Estudio controlado de POLIMALTOSADO FÉRRICO (MALTOFER®) vs SULFATO FERROSO (FERINSOL®) en el tratamiento de anemia ferropénica en niños de 6 meses a 2 años
(Revista del AWGLA, Vol1 Nº1; 33-42) 2005
|
|
Ramírez F, Planchet J, Galarraga D, et Al.
Anemia ferropénica en niños. Rapidez de la respuesta al tratamiento con POLIMALTOSADO FÉRRICO (IPC) y FERRITINA (F o proteína férrica)
(Revista del AWGLA, jun 2006; 35-43) 2006
|
|
Galarraga T, Zacarías I, Yañez C, et Al.
Comparación del complejo de
HIERRO-POLIMALTOSA con SULFATO
FERROSO en términos de tolerancia y aceptabilidad en lactantes: un estudio abierto, cruzado y aleatorizado
(Revista del AWGLA, Vol.1 Nº1; 43-53) 2005
|
|
Jacobs P, Wood L, Bird A
Better Tolerance of Iron Polymaltose Complex
Compared with Ferrous Sulphate in the Treatment of
Anaemia
(Hematology, 2000, Vol. 5, pp. 77-83) 2000
|
|
Yage J, Hartfiel D
Neurologic Manifestations of Iron Deficiency
in Childhood
(Pediatr Neurol 2002 ;27 :85-92) 2002
|
|
Irwin J, Kirchner J
Anemia in Children
(Am Fam Physiciam Vol.64 Nº8; 1379-1386) 2001
|
|
Walter T, Zacarías I, Yañez C
Tolerance and acceptability in infants
of Iron Polymaltose Complex
(Ars Medici no.9 2005 ::428-431) 2005
|
|
| |
|
|
|
Erichsen K, Ulvik R, Grimstad T, et Al
Effects of ferrous sulphate and non-ionic iron–polymaltose complex on
markers of oxidative tissue damage in patients with inflammatory
bowel disease
(Aliment Pharmacol Ther 2005; 22: 831–838) 2005 |
|
Ganz T, Nemeth E
Iron imports.
IV. Hepcidin and regulation of body iron metabolism
(Am J Physiol Gastrointest Liver Physiol 290: G199–G203, 2006;
doi:10.1152/ajpgi.00412.2005) 2005 |
|
Fisher A, Naughton D
Iron supplements: the quick fix with long-term consequences
(Nutrition Journal 2004, 3:2) 2004 |
|
| |
|
| |
|
Trabajos Científicos